Home / News Article

NeuralBase AI Ltd. Enhances Enterprise Wellness with HeartEase Acquisition

Reportable - Pharma and Biotech News July 30, 2025
By Reportable Staff
Read Original Article →
NeuralBase AI Ltd. Enhances Enterprise Wellness with HeartEase Acquisition

Summary

NeuralBase AI Ltd. acquires HeartEase, integrating AI-powered heart health screening into its chatbot ecosystem to meet corporate demand for comprehensive employee wellness solutions.

Full Article

NeuralBase AI Ltd. (OTC: NBBI), through its enterprise brand BMP AI, has made a strategic acquisition of HeartEase, an AI-powered diagnostic platform that leverages smartphone microphones for early detection of heart abnormalities. This move signifies a pivotal advancement in embedding preventive healthcare solutions within the enterprise AI chatbot ecosystem, catering to the escalating demand for holistic employee wellness programs.

The integration of HeartEase into BMP AI's platform introduces a non-invasive, accessible, and real-time solution for heart health screening, requiring no external hardware beyond a smartphone. This technology is set to transform enterprise wellness initiatives by facilitating preventive health screenings as part of the employees' daily digital interactions. Vighnesh Dobale, CEO of NeuralBase, articulated the transformative impact of HeartEase, highlighting its potential to revolutionize early detection of heart conditions through AI and mobile technology.

HeartEase's standout features include its smartphone-only diagnostics capability, global accessibility, commitment to privacy, and a scalable framework for future health screenings. With its AI engine already trained on validated clinical datasets, HeartEase is on track to launch a Minimum Viable Product (MVP) by Q4 2025, aimed at enterprise clients, wellness programs, and rural health initiatives.

This acquisition not only broadens the scope of BMP AI's chatbot platform but also reinforces the critical role of technology in fostering individual health and empowerment. It reflects a growing acknowledgment of the return on investment in employee wellness, from lowering healthcare expenses to enhancing productivity and staff retention. NeuralBase's dedication to developing scalable, ethical, and inclusive technologies is clearly demonstrated through this acquisition, setting a new benchmark in AI-driven preventive healthcare. For further details, visit https://www.sec.gov.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire